Skip to main content
. 2021 Jul 12;11:663556. doi: 10.3389/fonc.2021.663556

Figure 11.

Figure 11

Prognostic biomarker-drug interaction network of the hub RBPs in breast cancer. The network illustrated some available chemicals that would increase or decrease the expression levels and/or activity of MRPL12 (A), MRPL13 (B) and/or POP1 (C). The triangle arrow presented up-regulation, while the vertical arrow presented down-regulation. Moreover, the chemicals which be highlighted by navy blue were predicted as the communal chemical that might influence these three hub RBPs, simultaneously.